Tau Biomarkers in Late-onset Psychosis (LOP)

Recruiting Observational Study
Late Onset Schizophrenia Delusional Disorder (Late Onset)
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
65 – 85
Sex
Any
Study type
Observational
Participants needed
16 (estimated)
Sponsor
Jeremy Koppel · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

Hallucinations or delusions that occur for the first time in older people with no acute medical problems or mood symptoms may be related to impending dementia. This study aims to confirm this hypothesis using novel blood biomarkers and Positron Emission Tomography (PET) imaging tracers, as well as non-invasive testing.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Male or female, aged 65-85 years. 2. Diagnosis of late-onset non-affective primary psychotic disorder consistent with either very late-onset schizophrenia-like psychosis (VLOSP, International Late-Onset Schizophrenia Group consensus criteria, Howard et al., 2000) or delusiona…
Contacts

Nichole Hoehn, MS

516-562-3492

nhoehn@northwell.edu

CONTACT

Erica Christen, MS

516-562-3492

EChriste@northwell.edu

CONTACT